by admin | Apr 22, 2024 | Article
March 23, 2020 – Lupus Canada and the Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus (CaNIOS) are calling on the Government of Canada to ensure critical supply of hydroxychloroquine for Canadians living with lupus. “Like all Canadians, we are...
by admin | Apr 22, 2024 | Article
We’ve heard you – Canadians living with lupus are having problems filling their prescriptions of hydroxychloroquine. Take a read of the issue in CTV’s article and spread the word....
by admin | Apr 22, 2024 | Article
While the global coronavirus pandemic escalates. it’s understandable that many employees are nervous about heading into work every day – particularly those with lupus or other autoimmune conditions. Employers have a positive obligation to take reasonable care to...
by admin | Apr 22, 2024 | Article
Canadian Rheumatology Association Position Statement on COVID-19 and Hydroxychloroquine Supply The Canadian Rheumatology Association (CRA) is committed to supporting its members in their efforts to continue to deliver optimal care for their patients with rheumatic...
by admin | Apr 22, 2024 | Article
Canadian lupus patients missing critical drug after claims it treats coronavirus. To read the full story visit https://globalnews.ca/news/6761222/hydroxychloroquine-lupus-coronavirus-drug
by admin | Apr 22, 2024 | Article
“Hydroxychloroquine has long been a standard treatment for lupus and rheumatoid arthritis patients. But many of them have reported having trouble obtaining it, said Leanne Mielczarek, executive director of Lupus Canada. ‘They are experiencing difficulty,’ she said....
